Insider Trading & Ownership - Fontenot Jason D.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Fontenot Jason D.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-11-25
Tax Withholding
2023-11-28
4:18 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
1,030$0.3821136,270
(Direct)
View
2023-08-25
Tax Withholding
2023-08-29
4:15 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
1,029$0.77137,300
(Direct)
View
2023-05-25
Tax Withholding
2023-05-30
4:42 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
1,029$1.33138,329
(Direct)
View
2023-02-25
Tax Withholding
2023-03-06
5:07 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
6,559$2.66338,858
(Direct)
View
2023-02-24
Option Award
2023-03-06
5:07 pm
N/A
2033-02-23
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
242,250$0338,858
(Direct)
View
2022-04-25
Tax Withholding
2022-04-27
5:09 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
826$4.83103,167
(Direct)
View
2022-02-25
Tax Withholding
2022-03-01
5:18 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
6,248$5.9225,763
(Direct)
View
2022-02-25
Option Award
2022-03-01
5:18 pm
N/A
2032-02-24
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
166,870$0225,763
(Direct)
View
2021-04-25
Tax Withholding
2021-04-27
8:49 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
811$11.7162,496
(Direct)
View

Ownership
2021-03-19
7:15 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMOFontenot Jason D.
SVP, Chief Scientific Officer
0$0257,307
(Direct)
View